Tim Walbert, Horizon Therapeutics CEO (via YouTube)
December 11, 2022 02:29 PM ESTUpdated 03:01 PM
Deals
Pharma

Up­dat­ed: Am­gen in ad­vanced talks for Hori­zon, WSJ re­ports; Sanofi pulls out

Drew Armstrong

Executive Editor

Drug­mak­ers Hori­zon and Am­gen are in ad­vanced talks about a deal, the Wall Street Jour­nal re­port­ed Sun­day, while Sanofi sep­a­rate­ly an­nounced Sun­day that it has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times